ArticleEye (London, England)2023
Preserflo microshunt implant for the treatment of refractory uveitic glaucoma: 36-month outcomes.
Giacinto Triolo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this papercites it